Physician

Abdussami Hadi, M.D.

According to 2025 Medicare claims, Abdussami Hadi, M.D. (NPI: 1649413709) practices physical medicine and rehabilitation in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is SHARIYAR HADI DO PC (NPI: 1619206380; TIN: 264640772) and primary practice location at 11561-3212.

Hadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 402 traditional Medicare patients, billed 5,037 HCPCS/CPT codes, and received $457,357 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 4,254 prescription claims across 375 beneficiaries totaling $411,701 in drug costs, led by Oxycontin (Oxycodone Hcl). Open Payments data shows 31 records totaling $460. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,974 to $457,357. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	30	67	$5,974
2016	273	2,187	$99,246
2017	305	4,137	$214,694
2018	242	2,816	$216,014
2019	310	3,661	$264,135
2020	309	3,177	$257,370
2021	308	3,509	$292,811
2022	267	2,874	$276,202
2023	255	3,250	$280,703
2024	402	5,037	$457,357

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	209	996	$162,954
2016	372	3,293	$661,284
2017	325	2,766	$500,289
2018	291	2,801	$381,913
2019	343	2,988	$314,280
2020	334	3,442	$307,863
2021	334	3,458	$292,484
2022	353	3,682	$310,307
2023	424	4,254	$375,010
2024	375	4,254	$411,701

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	178	533	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	366	1,314	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	102	244	$71
80307	Testing for presence of drug, by chemistry analyzers	225	766	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	150	254	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	82	2,310	$60,620
Xtampza Er	Oxycodone Myristate	71	2,099	$51,319
Diclofenac Sodium	Diclofenac Sodium	119	3,106	$30,217
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	649	18,051	$26,169
Movantik	Naloxegol Oxalate	65	1,950	$25,934

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$460	Collegium Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdussami Hadi, M.D.?

Tedicare shows public-source Medicare data for Abdussami Hadi, M.D. (NPI 1649413709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdussami Hadi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdussami Hadi, M.D.?

Abdussami Hadi, M.D. is linked to SHARIYAR HADI DO PC (billing NPI 1619206380) in the available physician profile data.

Does Abdussami Hadi, M.D. have Open Payments data?

Abdussami Hadi, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.